These findings provide novel insight into IQGAP1 as a potential therapeutic target for inflammation- and angiogenesis-dependent ischemic diseases including peripheral vascular disease, arteriosclerosis, and wound healing, as well as tumor progression. The gene discussed is IQGAP1; the disease is vascular disorder.